Whitehawk Therapeutics Completes Asset Acquisition/Disposition
Ticker: WHWK · Form: 8-K · Filed: Mar 26, 2025 · CIK: 1422142
| Field | Detail |
|---|---|
| Company | Whitehawk Therapeutics, INC. (WHWK) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, disposition, corporate-event
TL;DR
Whitehawk just closed a deal on assets - big changes coming.
AI Summary
On March 25, 2025, Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc. and Aerpio Pharmaceuticals, Inc.) filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing indicates a significant corporate event has occurred, though specific details of the transaction, including the counterparty and financial terms, are not immediately available in this excerpt.
Why It Matters
This filing signals a material change in Whitehawk Therapeutics' assets, which could impact its business strategy, financial standing, and future operations.
Risk Assessment
Risk Level: medium — The completion of an acquisition or disposition of assets is a significant event that can introduce new risks or alter existing ones for the company.
Key Players & Entities
- Whitehawk Therapeutics, Inc. (company) — Registrant
- Aadi Bioscience, Inc. (company) — Former Company Name
- Aerpio Pharmaceuticals, Inc. (company) — Former Company Name
- ZETA ACQUISITION CORP II (company) — Former Company Name
- March 25, 2025 (date) — Date of earliest event reported
FAQ
What specific assets were acquired or disposed of by Whitehawk Therapeutics?
The provided excerpt does not specify the exact assets involved in the acquisition or disposition.
Who was the counterparty in this acquisition or disposition transaction?
The filing excerpt does not name the other party involved in the transaction.
What is the financial impact of this transaction on Whitehawk Therapeutics?
Specific financial details, such as the dollar amount of the transaction, are not included in this excerpt.
When did the reported event of asset acquisition or disposition officially conclude?
The report indicates the earliest event date as March 25, 2025.
What is the primary business of Whitehawk Therapeutics, Inc.?
Whitehawk Therapeutics, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 26, 2025 regarding Whitehawk Therapeutics, Inc. (WHWK).